Patent Grant
9023150
This application is a divisional of U.S. patent application Ser. No. 12/825,004, entitled “Acid Soluble Cement Kiln Dust Cementing Compositions and Sorel Cement Compositions Using CKD and/or Pumicite and Methods of Use,” filed on Jun. 28, 2010, which is a continuation-in-part of United Stated patent application Ser. No. 12/606,381, entitled “Methods of Cementing Subterranean Formation Formations Using Cement Kiln Dust in Compositions Having Reduced Portland Cement Content,” filed on Oct. 27, 2009, issued as U.S. Pat. No. 7,743,828, which is a continuation-in-part of U.S. application Ser. No. 12/420,630, entitled “Settable Compositions Comprising a Natural Pozzolan and Associated Methods,” filed on Apr. 8, 2009, issued as U.S. Pat. No. 7,631,692, which is a continuation-in-part of U.S. patent application Ser. No. 12/349,676, “Extended Settable Compositions Comprising Cement Kiln Dust and Associated Methods,” filed on Jan. 7, 2009, issued as U.S. Pat. No. 7,674,332, entitled which is a divisional of U.S. patent application Ser. No. 12/034,886, entitled “Extended Settable Compositions Comprising Cement Kiln Dust and Associated Methods, filed on Feb. 21, 2008, issued as U.S. Pat. No. 7,478,675, which is a continuation-in-part of U.S. patent application Ser. No. 11/223,669, entitled “Settable Compositions Comprising Cement Kiln Dust and Additive(s),” filed Sep. 9, 2005, issued as U.S. Pat. No. 7,445,669, the entire disclosures of which are incorporated herein by reference.
The present invention relates to cementing operations and, more particularly, in certain embodiments, to acid-soluble cement compositions that comprise cement kiln dust (“CKD”) and/or a natural pozzolan and associated methods of use.
Cement compositions may be used in a variety of subterranean applications. For example, in subterranean well construction, a pipe string (e.g., casing, liners, expandable tubulars, etc.) may be run into a well bore and cemented in place. The process of cementing the pipe string in place is commonly referred to as “primary cementing.” In a typical primary cementing method, a cement composition may be pumped into an annulus between the walls of the well bore and the exterior surface of the pipe string disposed therein. The cement composition may set in the annular space, thereby forming an annular sheath of hardened, substantially impermeable cement (i.e., a cement sheath) that may support and position the pipe string in the well bore and may bond the exterior surface of the pipe string to the subterranean formation. Among other things, the cement sheath surrounding the pipe string functions to prevent the migration of fluids in the annulus, as well as protecting the pipe string from corrosion. Cement compositions also may be used in remedial cementing methods, for example, to seal cracks or holes in pipe strings or cement sheaths, to seal highly permeable formation zones or fractures, to place a cement plug, and the like. Cement compositions also may be used in surface applications, for example, construction cementing.
In some applications, it may be desirable for the cement composition to be acid soluble. For instance, an acid-soluble cement composition may be desirable in applications where it is anticipated that the hardened cement will be removed in subsequent well bore operations. One particular application includes use of an acid-soluble cement composition to plug permeable zones in a formation that may allow the undesired flow of fluid into, or from, the well bore. For example, the permeable zones may result in the loss of circulation of fluids, such as a drilling fluid or a cement composition, in the well bore or an undesired influx of gas or water into the well bore. The permeable zones include, for example, vugs, voids, fractures (natural or otherwise produced) and the like. Other applications for acid-soluble cement compositions include, for example, the formation of annular plugs and isolation of gravel-packed well bore intervals. Examples of acid-soluble cement compositions include those comprising Sorel cements and Portland cements.
The present invention relates to cementing operations and, more particularly, in certain embodiments, to acid-soluble cement compositions that comprise CKD and/or a natural pozzolan and associated methods of use.
An embodiment of the present invention provides a method of cementing. The method may comprise placing an acid-soluble cement composition in a subterranean formation. The acid-soluble cement composition may comprise a hydraulic cement, a component selected from the group consisting of cement kiln dust, pumicite, and a combination thereof, and water. The method may further comprise allowing the acid-soluble cement composition to set. The method may further comprise contacting the set acid-soluble cement composition with an acid to dissolve the set acid-soluble cement composition.
Another embodiment of the present invention provides a method of cementing. The method may comprise placing an acid-soluble cement composition in a subterranean formation. The acid-soluble cement composition may comprise Portland cement, cement kiln dust, an acid-soluble filler, and water. The method may further comprise allowing the cement composition to set. The method may further comprise contacting the set acid-soluble cement composition with an acid to dissolve the set acid-soluble cement composition.
Yet another embodiment of the present invention provides a cement composition comprising: hydraulic cement; a component selected from the group consisting of cement kiln dust, pumicite, and a combination thereof; and water. The cement composition may be acid-soluble.
The features and advantages of the present invention will be readily apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
The present invention relates to cementing operations and, more particularly, in certain embodiments, to acid-soluble cement compositions that comprise CKD and/or a natural pozzolan and associated methods of use.
There may be several potential advantages to the methods and compositions of the present invention, only some of which may be alluded to herein. One of the many potential advantages of embodiments of the present invention is that the inclusion of the CKD and/or natural pozzolan in the acid-soluble cement composition should reduce the amount of, or potentially eliminate, a higher cost additive, such as Portland or Sorel cement, resulting in a more economical cement composition. Another potential advantage of embodiments of the present invention is that reduction of the amount of Portland cement should reduce the carbon footprint of the acid-soluble cement composition.
Embodiments of the acid-soluble cement compositions of the present invention may comprise: a hydraulic cement; a component selected from the group consisting of CKD, a natural pozzolan, and a combination thereof; and water. In an embodiment, the hydraulic cement may comprise Sorel cement. In another embodiment, the cement compositions may further comprise an acid-soluble filler. In yet another embodiment, the cement compositions may further comprise a source of calcium ions (e.g., hydrated lime). Other optional additives may also be included in embodiments of the cement compositions of the present invention as desired, including, but not limited to, fly ash, slag cement, metakaolin, shale, zeolite, combinations thereof, and the like. Additionally, embodiments of the cement compositions of the present invention may be foamed and/or extended as desired by those of ordinary skill in the art.
The acid-soluble cement compositions of the present invention should have a density suitable for a particular application as desired by those of ordinary skill in the art, with the benefit of this disclosure. In some embodiments, the cement compositions of the present invention may have a density in the range of from about 8 pounds per gallon (“ppg”) to about 16 ppg. In other embodiments, the cement compositions may be foamed to a density in the range of from about 8 ppg to about 13 ppg.
Embodiments of the acid-soluble cement compositions of the present invention may comprise a hydraulic cement. A variety of hydraulic cements may be utilized in accordance with the present invention, including, but not limited to, those comprising calcium, aluminum, silicon, oxygen, iron, and/or sulfur, which set and harden by reaction with water. Suitable hydraulic cements include, but are not limited to, Sorel cements, Portland cements, pozzolana cements, gypsum cements, high alumina content cements, slag cements, silica cements, and combinations thereof. In certain embodiments, the hydraulic cement may comprise a Portland cement. In some embodiments, the Portland cements that are suited for use in the present invention are classified as Classes A, C, G, and H cements according to American Petroleum Institute, API Specification for Materials and Testing for Well Cements, API Specification 10, Fifth Ed., Jul. 1, 1990. In addition, in some embodiments, cements suitable for use in the present invention may be classified as ASTM Type I, II, or III. As will be discussed in more detail below, acid-soluble fillers can be used with hydraulic cements (such as Portland cement) that do harden into an acid-soluble mass.
Where present, the hydraulic cement generally may be included in the acid-soluble cement compositions in an amount sufficient to provide the desired compressive strength, density, and/or cost. In accordance with embodiments, at least a portion of the hydraulic cement may be replaced with CKD and/or a natural pozzolan. In an embodiment, at a least a portion of the hydraulic cement is replaced with CKD and/or a natural pozzolan. In some embodiments, the hydraulic cement may be present in the cement compositions of the present invention in an amount in the range of 0% to about 99% by weight of cementitious components. Cementitious components include those components or combinations of components of the cement compositions that hydraulically set, or otherwise harden, to develop compressive strength, including, for example, Sorel cement, Portland cement, CKD, fly ash, pumice, slag, lime, shale, and the like. The hydraulic cement may be present, in certain embodiments, in an amount of about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 90%, or about 95%. In an embodiment, the hydraulic cement may be present in an amount in the range of 0% to about 95% by weight of cementitious components. In another embodiment, the hydraulic cement may be present in an amount in the range of about 20% to about 95% by weight of cementitious components. In yet another embodiment, the hydraulic cement may be present in an amount in the range of about 50% to about 90% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the hydraulic cement to include for a chosen application.
An example of a suitable hydraulic cement comprises a Sorel cement. Sorel cements typically include magnesia-based cement systems formed from a mixture of magnesium oxide and magnesium chloride. However, as used herein, the term “Sorel cement” is intended to encompass any of a variety of metal oxides and soluble salts which together form a hydraulic cement. In the presence of water, the metal oxide and the soluble salt forming the Sorel cement should solidify into an acid-soluble mass. Embodiments of the Sorel cements should rapidly develop a desirable compressive strength. In accordance with embodiments, at least a portion of the Sorel cement may be replaced with CKD and/or a natural pozzolan. In an embodiment, at a least a portion of the soluble salt is replaced with CKD and/or a natural pozzolan.
In an embodiment, the Sorel cement comprises a metal oxide. In one particular embodiment, the Sorel cement comprises an alkaline earth metal oxide, such as magnesium oxide. A suitable metal oxide is THERMATEK™ LT additive, available from Halliburton Energy Services, Inc. The metal oxide present in the Sorel cement should have an activity level sufficient to provide the desired reactivity. For example, the higher the activity level of the metal oxide, the faster the reaction of the metal oxide with the other components of the Sorel cement to form the hardened mass. The activity level of the metal oxide may vary based on a number of factors. For example, the particle size differential of the metal oxide particles may affect the activity level. A smaller particle size differential may result in a higher activity level due, inter alia, to a greater surface area. Another factor that may affect the activity level of the metal oxide is a sintering process. By varying the heat applied during, and time of, the sintering process, metal oxide with varying activity levels may be provided. Metal oxide that has not been treated by a sintering process may have a very high activity level, and thus it may be highly reactive in the Sorel cements. In an embodiment, a relatively more reactive metal oxide may be desired, such as where it may be desired to have a cement composition with a relatively short set time, for example, when desired to rapidly seal off a permeable zone. In an alternative embodiment, a relatively less reactive metal oxide may be desired, for example, where a delay may be desired between mixing the cement composition and the formation of a hardened mass.
A wide variety of soluble salts are suitable for use in the Sorel cement, including metal chlorides. In one embodiment, the Sorel cement comprises an alkaline earth metal chloride, such as magnesium chloride. An example of a suitable magnesium chloride is C-TEK additive, available from Halliburton Energy Services, Inc. In an alternative embodiment, the Sorel cement comprises magnesium sulfate or ammonium mono or dibasic phosphate.
In an embodiment, the Sorel cement may comprise the metal oxide and the soluble salt in a metal-oxide-to-soluble-salt ratio of about 3:1 to about 1:3. In another embodiment, the metal-oxide-to-soluble-salt ratio may range from about 2:1 to about 1:2. In yet another embodiment, the metal-oxide-to-soluble-salt ratio may range from about 1.5:1 to about 1:1.5. One of ordinary skill in the art will recognize the appropriate ratio of the metal oxide and soluble salt to include for a particular application.
Embodiments of the acid-soluble cement compositions generally may comprise CKD, which is a material generated in the manufacture of cement. CKD, as that term is used herein, refers to a partially calcined kiln feed which is removed from the gas stream and collected, for example, in a dust collector during the manufacture of cement. Usually, large quantities of CKD are collected in the production of cement that are commonly disposed of as waste. Disposal of the CKD as waste can add undesirable costs to the manufacture of the cement, as well as the environmental concerns associated with its disposal. The chemical analysis of CKD from various cement manufactures varies depending on a number of factors, including the particular kiln feed, the efficiencies of the cement production operation, and the associated dust collection systems. CKD generally may comprise a variety of oxides, such as SiO2, Al2O3, Fe2O3, CaO, MgO, SO3, Na2O, and K2O. The term “CKD” is used herein to mean cement kiln dust made as described above and equivalent forms of cement kiln dust made in other ways.
The CKD generally may exhibit cementitious properties, in that it may set and harden in the presence of water. In accordance with embodiments of the present invention, the CKD may be used, among other things, to replace higher cost cementitious components, such as Portland cement and/or Sorel cement, resulting in more economical cement compositions. In addition, substitution of the CKD for the Portland and/or Sorel cement should result in a cement composition with a reduced carbon footprint.
The CKD may be included in the acid-soluble cement compositions in an amount sufficient to provide the desired compressive strength, density, cost reduction, and/or reduced carbon footprint. In some embodiments, the CKD may be present in the cement compositions of the present invention in an amount in the range of from about 1% to about 100% by weight of cementitious components. For example, the CKD may be present in an amount of about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 90%, or about 95%. In one embodiment, the CKD may be present in an amount in the range of from about 5% to about 99% by weight of cementitious components. In another embodiment, the CKD may be present in an amount in the range of from about 5% to about 80% by weight of cementitious components. In yet another embodiment, the CKD may be present in an amount in the range of from about 50% to about 80% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of CKD to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise a natural pozzolan. Natural pozzolans are generally present on the Earth's surface and set and harden in the presence of hydrated lime and water. Examples of natural pozzolans include pumicite, diatomaceous earth, volcanic ash, opaline shale, tuff, and combinations thereof. Generally, pumicite is a volcanic rock that exhibits cementitious properties, in that it may set and harden in the presence of a source of calcium ions and water. Hydrated lime may be used in combination with the pumicite, for example, to provide sufficient calcium ions for the pumicite to set. The natural pozzolan may be used, among other things, to replace higher cost cementitious components, such as Portland or Sorel cement, in embodiments of the sealant compositions, resulting in more economical sealant compositions. In addition, substitution of the natural pozzolan for the Portland cement and/or Sorel cement should result in a cement composition with a reduced carbon footprint.
Where present, the natural pozzolan may be included in an amount sufficient to provide the desired compressive strength, density, cost reduction and/or reduced carbon footprint for a particular application. In some embodiments, the natural pozzolan may be present in the acid-soluble cement compositions of the present invention in an amount in the range of from about 1% to about 100% by weight of cementitious components. For example, the natural pozzolan may be present in an amount of about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 90%, or about 95%. In one embodiment, the natural pozzolan may be present in an amount in the range of from about 5% to about 99% by weight of cementitious components. In another embodiment, the natural pozzolan may be present in an amount in the range of from about 5% to about 80% by weight of cementitious components. In yet another embodiment, the natural pozzolan may be present in an amount in the range of from about 10% to about 50% by weight of cementitious components. In yet another embodiment, the natural pozzolan may be present in an amount in the range of from about 25% to about 50% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the natural pozzolan to include for a chosen application.
The water that may be used in embodiments of the cement compositions may include, for example, freshwater, saltwater (e.g., water containing one or more salts dissolved therein), brine (e.g., saturated saltwater produced from subterranean formations), seawater, or combinations thereof. Generally, the water may be from any source, provided that the water does not contain an excess of compounds that may undesirably affect other components in the cement composition. In some embodiments, the water may be included in an amount sufficient to a pumpable slurry. In some embodiments, the water may be included in the cement compositions of the present invention in an amount in the range of about 40% to about 200% by weight of cementitious components. In some embodiments, the water may be included in an amount in the range of about 40% to about 150% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of water to include for a chosen application.
Embodiments of the cement compositions may further comprise a source of calcium ions, such as lime. In certain embodiments, the source of calcium ions may include hydrated lime. The source of calcium ions may be included in embodiments of the cement compositions, for example to, form a hydraulic composition with other components of the cement compositions, such as the pumice, fly ash, slag, and/or shale. Where present, the lime may be included in the cement compositions in an amount sufficient for a particular application. In some embodiments, the lime may be present in an amount in the range of from about 1% to about 40% by weight of cementitious components. For example, the lime may be present in an amount of about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, or about 35%. In one embodiment, the lime may be present in an amount in the range of from about 5% to about 20% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the lime to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise an acid-soluble filler. The acid-soluble filler may be used, for example, in compositions that comprise Portland cement with the acid-soluble filler providing an acid-soluble component so that the compositions can be dissolved and removed. In an embodiment, the acid-soluble filler is present in a cement composition comprising a Sorel cement. Examples of suitable acid-soluble filler include dolomite, magnesium carbonate, calcium carbonate, and zinc carbonate. Where used, the acid-soluble filler may present in the acid-soluble cement composition in an amount of from about 0.1% to about 300% by weight of the cementitious component. In an embodiment, the acid-soluble filler is present in an amount of from about 50% to about 400% by weight of the cementitious component. In an embodiment, the acid-soluble filler is present in an amount of from about 100% to about 300% by weight of the cementitious component. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the acid-soluble filler to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise fly ash. A variety of fly ashes may be suitable, including fly ash classified as Class C and Class F fly ash according to American Petroleum Institute, API Specification for Materials and Testing for Well Cements, API Specification 10, Fifth Ed., Jul. 1, 1990. Class C fly ash comprises both silica and lime so that, when mixed with water, it should set to form a hardened mass. Class F fly ash generally does not contain sufficient lime, so an additional source of calcium ions is required for the Class F fly ash to faun a hydraulic composition. In some embodiments, lime may be mixed with Class F fly ash in an amount in the range of about 0.1% to about 25% by weight of the fly ash. In some instances, the lime may be hydrated lime. Suitable examples of fly ash include, but are not limited to, POZMIX® A cement additive, commercially available from Halliburton Energy Services, Inc., Duncan, Okla.
Where present, the fly ash generally may be included in the acid-soluble cement compositions in an amount sufficient to provide the desired compressive strength, density, and/or cost. In some embodiments, the fly ash may be present in the cement compositions of the present invention in an amount in the range of about 5% to about 75% by weight of cementitious components. In some embodiments, the fly ash may be present in an amount in the range of about 10% to about 60% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the fly ash to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise a slag cement. In some embodiments, a slag cement that may be suitable for use may comprise slag. Slag generally does not contain sufficient basic material, so slag cement may further comprise a base to produce a hydraulic composition that may react with water to set to form a hardened mass. Examples of suitable sources of bases include, but are not limited to, sodium hydroxide, sodium bicarbonate, sodium carbonate, lime, and combinations thereof.
Where present, the slag cement generally may be included in the acid-soluble cement compositions in an amount sufficient to provide the desired compressive strength, density, and/or cost. In some embodiments, the slag cement may be present in the cement compositions of the present invention in an amount in the range of about 0.1% to about 99% by weight of cementitious components. In some embodiments, the slag cement may be present in an amount in the range of about 5% to about 75% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the slag cement to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise metakaolin. Generally, metakaolin is a white pozzolan that may be prepared by heating kaolin clay, for example, to temperatures in the range of about 600° C. to about 800° C. In some embodiments, the metakaolin may be present in the cement compositions of the present invention in an amount in the range of about 5% to about 95% by weight of cementitious components. In some embodiments, the metakaolin may be present in an amount in the range of about 10% to about 50% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the metakaolin to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise shale. Among other things, shale included in the cement compositions may react with excess lime to foam a suitable cementing material, for example, calcium silicate hydrate. A variety of shales may be suitable, including those comprising silicon, aluminum, calcium, and/or magnesium. An example of a suitable shale comprises vitrified shale. Suitable examples of vitrified shale include, but are not limited to, PRESSUR-SEAL FINE LCM material and PRESSUR-SEAL COARSE LCM material, which are commercially available from TXI Energy Services, Inc., Houston, Tex. Generally, the shale may have any particle size distribution as desired for a particular application. In certain embodiments, the shale may have a particle size distribution in the range of about 37 micrometers to about 4,750 micrometers.
Where present, the shale may be included in the acid-soluble cement compositions of the present invention in an amount sufficient to provide the desired compressive strength, density, and/or cost. In some embodiments, the shale may be present in the cement compositions of the present invention in an amount in the range of about 5% to about 75% by weight of cementitious components. In some embodiments, the shale may be present in an amount in the range of about 10% to about 35% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the shale to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise zeolite. Zeolites generally are porous alumino-silicate minerals that may be either a natural or synthetic material. Synthetic zeolites are based on the same type of structural cell as natural zeolites, and may comprise aluminosilicate hydrates. As used herein, the term “zeolite” refers to all natural and synthetic forms of zeolite. Examples of suitable zeolites are described in more detail in U.S. Pat. No. 7,445,669. An example of a suitable source of zeolite is available from the C2C Zeolite Corporation of Calgary, Canada. In some embodiments, the zeolite may be present in the cement compositions of the present invention in an amount in the range of about 5% to about 65% by weight of cementitious components. In certain embodiments, the zeolite may be present in an amount in the range of about 10% to about 40% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the zeolite to include for a chosen application.
Embodiments of the acid-soluble cement compositions may further comprise a set retarding additive. As used herein, the term “set retarding additive” refers to an additive that retards the setting of the acid-soluble cement compositions of the present invention. Examples of suitable set retarding additives include, but are not limited to, ammonium, alkali metals, alkaline earth metals, metal salts of sulfoalkylated lignins, organic acids (e.g., hydroxycarboxy acids), copolymers that comprise acrylic acid or maleic acid, and combinations thereof. One example of a suitable sulfoalkylate lignin comprises a sulfomethylated lignin. Suitable set retarding additives are disclosed in more detail in U.S. Pat. No. Re. 31,190, the entire disclosure of which is incorporated herein by reference. Suitable set retarding additives are commercially available from Halliburton Energy Services, Inc. under the trademarks HR® 4, HR® 5, HR® 7, HR® 12, HR®15, HR®25, HR 601, SCR™ 100, and SCR™ 500 retarders. Generally, where used, the set retarding additive may be included in the cement compositions of the present invention in an amount sufficient to provide the desired set retardation. In some embodiments, the set retarding additive may be present in the cement compositions of the present invention an amount in the range of about 0.1% to about 5% by weight of cementitious components. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of the set retarding additive to include for a chosen application.
Optionally, other additional additives may be added to the acid-soluble cement compositions of the present invention as deemed appropriate by one skilled in the art, with the benefit of this disclosure. Examples of such additives include, but are not limited to, strength-retrogression additives, set accelerators, weighting agents, lightweight additives, gas-generating additives, mechanical property enhancing additives, lost-circulation materials, filtration-control additives, dispersants, fluid loss control additives, defoaming agents, foaming agents, oil-swellable particles, water-swellable particles, thixotropic additives, and combinations thereof. Specific examples of these, and other, additives include crystalline silica, amorphous silica, fumed silica, salts, fibers, hydratable clays, microspheres, rice husk ash, elastomers, elastomeric particles, resins, latex, combinations thereof, and the like. A person having ordinary skill in the art, with the benefit of this disclosure, will readily be able to determine the type and amount of additive useful for a particular application and desired result.
As will be appreciated by those of ordinary skill in the art, the acid-soluble cement compositions of the present invention may be used in subterranean operations in accordance with embodiments of the present invention. Without limitation, the cement composition may be used to seal off one or more subterranean zones from a well bore; to plug a void or crack in a conduit disposed in the well bore; to plug a void or crack in a cement sheath disposed in the well bore; to plug an opening between the cement sheath and the conduit; to prevent the loss of fluid from the well bore into loss circulation zones such as a void, vug, or fracture; to form an annular plug; to isolate a gravel packed interval of the well bore; or combinations thereof. In an embodiment, the acid-soluble cement composition may be used to form a selectively removable barrier (e.g., a plug, a seal, etc.) in a subterranean formation.
An example of a method of the present invention comprises placing an acid-soluble cement composition in a subterranean formation, and allowing the acid-soluble cement composition to set in the formation. It is intended to be understood that the phrase “placing an acid-soluble cement composition in the subterranean formation” encompasses placement of the cement composition in the well bore and/or placement of the cement composition in rock surrounding the well bore with the well bore penetrating the subterranean formation. The cement composition should form a hardened mass in the subterranean formation. The hardened mass can be left in the subterranean formation permanently or can be removed. Removal of the hardened mass may be desired so that the subterranean formation can be utilized in subsequent hydrocarbon production in accordance with embodiments of the present invention. In an embodiment, removal of the hardened mass includes contacting the hardened mass with an aqueous acid composition to dissolve the hardened mass. The aqueous acid composition may include, for example, from about 7.5% to about 28% hydrochloric acid by weight of the composition. In an embodiment, the aqueous acid composition includes hydrochloric acid in an amount of about 15% by weight.
To facilitate a better understanding of the present invention, the following examples of certain aspects of some embodiments are given. In no way should the following examples be read to limit, or define, the scope of the invention.
A series of acid-soluble cement compositions was prepared at room temperature and subjected to crush strength and solubility testing. Each of the samples contained sufficient water to provide the density provided in the table below and comprised various quantities of Class H Portland cement, Holcim CKD, and/or calcium carbonate, as indicated in the table below.
Solubility Testing: For the solubility testing, each sample was poured into a 2-inch cube and allowed to cure in a water bath at 150° F. for either 48 hours (Samples 1-5) or 72 hours (Samples 6-10). After curing, the sample cubes are placed in an 80° F. water bath for at least 30 minutes and then weighed to determine an initial weight. Each sample cube was then submerged in 2,000 milliliters of a 15% by weight hydrochloric acid solution in a 3,000 milliliter beaker. The sample cube was supported in the acid solution above a magnetic stir bar. The magnetic stir bar was rotated to create a slight vortex on the surface of the acid solution. After 30 minutes, the sample cube was removed from the acid solution and weighted to determine a final weight. The acid solubility of each composition was calculated by the following formula:
Acid Solubility=Final Weight/(Initial Weight−Final Weight)×100
Crush Strength Testing: For the crush strength testing, each sample was poured into a 2-inch cube, allowed to cure in a water bath at 150° F. for 48 hours (Samples 1-5) or 72 hours (Samples 6-10), and then crushed. The crush strengths were determined using a Tinius Olson tester in accordance with API Specification 10.
The results of the tests are set forth in the table below. In the following table, percent by weight is based on the weight of the cement and the CKD in the samples.
Example 1 thus indicates that acid-soluble cement compositions containing from 25% to 100% CKD by weight, from 0% to 75% Portland cement by weight, and from 100% to 300% calcium carbonate by weight may have properties suitable for use in acid-soluble operations.
An additional series of acid-soluble cement compositions was prepared and subjected to thickening time, force resistance, and rheological tests. Each of the samples contained sufficient water to provide the density provided in the table below and comprised various quantities of Class H Portland cement, Holcim CKD, calcium carbonate, a dispersant (CFR™-3 cement friction reducer), and/or a set retarding additive, as indicated in the table below. In the following tables, percent by weight is based on the weight of the cement and the CKD in the samples.
The samples were prepared at room temperature with thickening time tests conducted at 140° F. on a portion of each composition in accordance with API Specification 10. The crush strength of Sample 12 was determined by pouring the sample into a 2-inch cube, allowing it to cure in a water bath at 160° F. for 72 hours, and then crushing the cured cube. The crush strength was determined using a Tinius Olson tester in accordance with API Specification 10. The results of the thickening time and force resistance tests are provided in the table below.
For the rheological tests, additional portions of the acid-soluble cement compositions were conditioned in an atmospheric consistometer to the test temperature. After conditioning, the rheology of the compositions was determined using a Fann Model 35 viscometer at the temperature indicated in the table below using a bob and sleeve and spring #1 in accordance with the procedure set forth in API Specification 10. The results of the rheological tests are set forth in the table below. In the following table, percent by weight is based on the weight of the cement and the CKD in the samples.
Example 2 thus indicates that acid-soluble cement compositions containing from 25% to 50% CKD by weight, from 50% to 75% Portland cement by weight, and 100% calcium carbonate by weight may have properties suitable for use in acid-soluble operations.
An additional acid-soluble cement composition was prepared to determine force resistance properties of compositions comprising pumicite. The composition contained sufficient water to provide the density provided in the table below and comprised Class H Portland cement, 200-mesh pumicite, calcium carbonate, a set retarding additive (HR®5 retarder), and hydrated lime, as indicated in the table below. For the acid solubility testing, the composition was poured into a 2-inch cube and cured at 180° F. for 24 hours. The acid solubility of the composition was then determined by submerging the cured cube in a 15% by weight hydrochloric acid solution in accordance with the procedure described above in Example 1. For the crush strength testing, the composition was poured into a 2-inch cube, allowed to cure in a water bath for 24 hours at 180° F., and then crushed. The 24-hour crush strength was determined using a Tinius Olson tester in accordance with API Specification 10. The results of the tests are set forth in the table below. In the following table, percent by weight is based on the weight of the cement and the CKD in the samples.
Example 3 thus indicates that acid-soluble cement compositions containing Portland cement, pumicite, and calcium carbonate may have properties suitable for use in acid-soluble operations.
An additional series of acid-soluble cement compositions was prepared at room temperature to determine force resistance properties of compositions comprising Sorel cement (e.g., a mixture of magnesium chloride and magnesium oxide), CKD, and/or pumicite. Each of the samples contained water, magnesium chloride (C-TEK), magnesium oxide (THERMATEK™ LT additive), Holcim CKD, 200-mesh pumicite, and/or hydrated lime, as indicated in the table below. The crush strength of the compositions was determined by pouring each composition into a 2-inch cube, allowing the cube to cure in a water bath at 140° F. for either 24 or 48 hours, and then crushing the cured cube. The crush strengths were determined using a Tinius Olson tester in accordance with API Specification 10. The results of the tests are set forth in the table below.
Example 4 thus indicates that acid-soluble cement compositions containing Sorel cement, cement kiln dust, and/or pumicite may have properties suitable for use in acid-soluble operations.
An additional series of acid-soluble cement compositions was prepared at room temperature to determine force resistance properties of lightweight compositions comprising Sorel cement (e.g., a mixture of magnesium chloride and magnesium oxide) and CKD. Each of the samples contained water, magnesium chloride (C-TEK additive), magnesium oxide (THERMATEK™ LT additive), Holcim CKD, a set retarding additive (R-TEK inhibitor), and glass bubbles (HGS 2000 glass bubbles), as indicated in the table below. The crush strength of the compositions was determined by pouring each composition into a 2-inch cube, allowing the cube to cure in a water bath at 140° F. for 24 hours, and then crushing the cured cube. The crush strengths were determined using a Tinius Olson tester in accordance with API Specification 10. The results of the tests are set forth in the table below.
Example 5 thus indicates that acid-soluble cement compositions having a lightweight and containing Sorel cement and cement kiln dust may have properties suitable for use in acid-soluble operations.
An additional series of acid-soluble cement compositions was prepared at room temperature and subjected to thickening time tests at 140° F. in accordance with API Specification 10. Each of the samples contained water, magnesium chloride (C-TEK additive), magnesium oxide (THERMATEK™ LT additive), Holcim CKD, and a retarder (R-TEK inhibitor) as indicated in the table below. The results of the tests are set forth in the table below.
Example 6 thus indicates that acid-soluble cement compositions containing Sorel cement and cement kiln dust may have properties suitable for use in acid-soluble operations.
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Although individual embodiments are discussed, the invention covers all combinations of all those embodiments. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. While compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range is specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2021956 | Gladney et al. | Nov 1935 | A |
| 2045899 | Davis | Jun 1936 | A |
| 2094316 | Cross et al. | Sep 1937 | A |
| 2133622 | Larmour et al. | Oct 1938 | A |
| 2193775 | Stratford | Mar 1940 | A |
| 2193807 | Dieterich | Mar 1940 | A |
| 2329940 | Ponzer | Sep 1943 | A |
| 2772739 | Arie | Dec 1956 | A |
| 2842205 | Allen et al. | Jul 1958 | A |
| 2848051 | Williams | Aug 1958 | A |
| 2871133 | Palonen et al. | Jan 1959 | A |
| 2880096 | Hurley | Mar 1959 | A |
| 2945769 | Gama et al. | Jul 1960 | A |
| 3066031 | Schifferle | Nov 1962 | A |
| 3168139 | Kennedy et al. | Feb 1965 | A |
| 3320077 | Prior | May 1967 | A |
| 3467193 | McColl et al. | Oct 1968 | A |
| 3411580 | Roberts et al. | Nov 1968 | A |
| 3421703 | Galer | Jan 1969 | A |
| 3454095 | Messenger et al. | Jul 1969 | A |
| 3473939 | Mayberry et al. | Oct 1969 | A |
| 3499491 | Wyant et al. | Mar 1970 | A |
| 3557876 | Tragesser | Jan 1971 | A |
| 3574816 | Abbdellatif et al. | Apr 1971 | A |
| 3628973 | Greening et al. | Dec 1971 | A |
| 3748159 | George | Jul 1973 | A |
| 3749173 | Hill et al. | Jul 1973 | A |
| 3863718 | Bruist | Feb 1975 | A |
| 3876005 | Fincher et al. | Apr 1975 | A |
| 3887009 | Miller et al. | Jun 1975 | A |
| 3887385 | Quist et al. | Jun 1975 | A |
| 3921717 | Danjushevsky | Nov 1975 | A |
| 3959007 | Pitt | May 1976 | A |
| 4018617 | Nicholson | Apr 1977 | A |
| 4018619 | Webster et al. | Apr 1977 | A |
| 4031184 | McCord | Jun 1977 | A |
| 4036301 | Powers et al. | Jul 1977 | A |
| 4083407 | Griffin et al. | Apr 1978 | A |
| 4101332 | Nicholson | Jul 1978 | A |
| 4105459 | Mehta | Aug 1978 | A |
| 4141843 | Watson | Feb 1979 | A |
| 4176720 | Wilson | Dec 1979 | A |
| 4268316 | Wills et al. | May 1981 | A |
| 4274881 | Langton | Jun 1981 | A |
| 4304300 | Watson | Dec 1981 | A |
| 4333764 | Richardson | Jun 1982 | A |
| 4335788 | Murphey et al. | Jun 1982 | A |
| 4341562 | Ahlbeck | Jul 1982 | A |
| RE31190 | Detroit et al. | Mar 1983 | E |
| 4400474 | Copperthwaite et al. | Aug 1983 | A |
| 4407677 | Wills et al. | Oct 1983 | A |
| 4432800 | Kneller et al. | Feb 1984 | A |
| 4435216 | Diehl et al. | Mar 1984 | A |
| 4436850 | Burdick et al. | Mar 1984 | A |
| 4460292 | Durham et al. | Jul 1984 | A |
| 4470463 | Holland | Sep 1984 | A |
| 4494990 | Harris | Jan 1985 | A |
| 4515635 | Rao et al. | May 1985 | A |
| 4519452 | Tsao et al. | May 1985 | A |
| 4555269 | Rao et al. | Nov 1985 | A |
| 4614599 | Walker | Sep 1986 | A |
| 4624711 | Styron | Nov 1986 | A |
| 4633950 | Delhommer et al. | Jan 1987 | A |
| 4676317 | Fry et al. | Jun 1987 | A |
| 4676832 | Childs et al. | Jun 1987 | A |
| 4741782 | Styron | May 1988 | A |
| 4784223 | Worrall et al. | Nov 1988 | A |
| 4829107 | Kindt | May 1989 | A |
| 4883125 | Wilson et al. | Nov 1989 | A |
| 4941536 | Brothers et al. | Jul 1990 | A |
| 4992102 | Barbour | Feb 1991 | A |
| 5030366 | Wilson et al. | Jul 1991 | A |
| 5049288 | Brothers et al. | Sep 1991 | A |
| 5058679 | Hale et al. | Oct 1991 | A |
| RE33747 | Hartley et al. | Nov 1991 | E |
| 5086850 | Harris et al. | Feb 1992 | A |
| 5113943 | Wilson et al. | May 1992 | A |
| 5121795 | Ewert et al. | Jun 1992 | A |
| 5123487 | Harris et al. | Jun 1992 | A |
| 5125455 | Harris et al. | Jun 1992 | A |
| 5127473 | Harris et al. | Jul 1992 | A |
| 5183505 | Spinney | Feb 1993 | A |
| 5213160 | Nahm et al. | May 1993 | A |
| 5213161 | King et al. | May 1993 | A |
| 5215585 | Luthra et al. | Jun 1993 | A |
| 5220960 | Totten et al. | Jun 1993 | A |
| 5238064 | Dahl et al. | Aug 1993 | A |
| 5252128 | Gopalkrishnan | Oct 1993 | A |
| 5266111 | Barbour | Nov 1993 | A |
| 5281270 | Totten et al. | Jan 1994 | A |
| 5290355 | Jakel | Mar 1994 | A |
| 5295543 | Terry et al. | Mar 1994 | A |
| 5298069 | King et al. | Mar 1994 | A |
| 5305831 | Nahm | Apr 1994 | A |
| 5314022 | Cowan et al. | May 1994 | A |
| 5316083 | Nahm et al. | May 1994 | A |
| 5327968 | Onan et al. | Jul 1994 | A |
| 5337824 | Cowan | Aug 1994 | A |
| 5339902 | Harris | Aug 1994 | A |
| 5346548 | Mehta | Sep 1994 | A |
| 5352288 | Mallow | Oct 1994 | A |
| 5358044 | Hale et al. | Oct 1994 | A |
| 5358049 | Hale et al. | Oct 1994 | A |
| 5361841 | Hale et al. | Nov 1994 | A |
| 5361842 | Hale et al. | Nov 1994 | A |
| 5368103 | Heathman et al. | Nov 1994 | A |
| 5370185 | Cowan et al. | Dec 1994 | A |
| 5372641 | Carpenter | Dec 1994 | A |
| 5382290 | Nahm et al. | Jan 1995 | A |
| 5383521 | Onan et al. | Jan 1995 | A |
| 5383967 | Chase | Jan 1995 | A |
| 5398758 | Onan et al. | Mar 1995 | A |
| 5417759 | Huddleston | May 1995 | A |
| 5423379 | Hale et al. | Jun 1995 | A |
| 5430235 | Hooykaas et al. | Jul 1995 | A |
| 5439056 | Cowan | Aug 1995 | A |
| 5456751 | Zandi et al. | Oct 1995 | A |
| 5458195 | Totten et al. | Oct 1995 | A |
| 5464060 | Hale et al. | Nov 1995 | A |
| 5472051 | Brothers | Dec 1995 | A |
| 5476144 | Nahm et al. | Dec 1995 | A |
| 5494513 | Fu et al. | Feb 1996 | A |
| 5499677 | Cowan | Mar 1996 | A |
| 5515921 | Cowan et al. | May 1996 | A |
| 5518996 | Maroy et al. | May 1996 | A |
| 5520730 | Barbour | May 1996 | A |
| 5529123 | Carpenter et al. | Jun 1996 | A |
| 5529624 | Riegler | Jun 1996 | A |
| 5536311 | Rodrigues | Jul 1996 | A |
| 5542782 | Carter et al. | Aug 1996 | A |
| 5554352 | Jaques et al. | Sep 1996 | A |
| 5569324 | Totten et al. | Oct 1996 | A |
| 5580379 | Cowan | Dec 1996 | A |
| 5585333 | Dahl et al. | Dec 1996 | A |
| 5588489 | Chatterji et al. | Dec 1996 | A |
| 5641584 | Andersen et al. | Jun 1997 | A |
| 5673753 | Hale et al. | Oct 1997 | A |
| 5681384 | Liskowitz | Oct 1997 | A |
| 5685903 | Stav et al. | Nov 1997 | A |
| 5688844 | Chatterji et al. | Nov 1997 | A |
| 5711383 | Terry et al. | Jan 1998 | A |
| 5716910 | Totten et al. | Feb 1998 | A |
| 5728654 | Dobson et al. | Mar 1998 | A |
| 5795924 | Chatterji et al. | Aug 1998 | A |
| 5820670 | Chatterji et al. | Oct 1998 | A |
| 5851960 | Totten et al. | Dec 1998 | A |
| 5866516 | Costin | Feb 1999 | A |
| 5866517 | Carpenter et al. | Feb 1999 | A |
| 5874387 | Carpenter et al. | Feb 1999 | A |
| 5897699 | Chatterji et al. | Apr 1999 | A |
| 5900053 | Brothers et al. | May 1999 | A |
| 5913364 | Sweatman | Jun 1999 | A |
| 5988279 | Udarbe et al. | Nov 1999 | A |
| 6022408 | Stokes et al. | Feb 2000 | A |
| 6060434 | Sweatman et al. | May 2000 | A |
| 6060535 | Villar et al. | May 2000 | A |
| 6063738 | Chatterji et al. | May 2000 | A |
| 6098711 | Chatterji et al. | Aug 2000 | A |
| 6138759 | Chatterji et al. | Oct 2000 | A |
| 6143069 | Brothers et al. | Nov 2000 | A |
| 6145591 | Boncan et al. | Nov 2000 | A |
| 6153562 | Villar et al. | Nov 2000 | A |
| 6167967 | Sweatman | Jan 2001 | B1 |
| 6170575 | Reddy et al. | Jan 2001 | B1 |
| 6230804 | Mueller et al. | May 2001 | B1 |
| 6244343 | Brothers et al. | Jun 2001 | B1 |
| 6245142 | Reddy et al. | Jun 2001 | B1 |
| 6258757 | Sweatman et al. | Jul 2001 | B1 |
| 6264738 | Lorke et al. | Jul 2001 | B1 |
| 6277189 | Chugh | Aug 2001 | B1 |
| 6312515 | Barlet-Gouedard et al. | Nov 2001 | B1 |
| 6315042 | Griffith et al. | Nov 2001 | B1 |
| 6328106 | Griffith et al. | Dec 2001 | B1 |
| 6332921 | Brothers et al. | Dec 2001 | B1 |
| 6367550 | Chatterji et al. | Apr 2002 | B1 |
| 6379456 | Heathman et al. | Apr 2002 | B1 |
| 6402833 | O'Hearn et al. | Jun 2002 | B1 |
| 6409819 | Ko | Jun 2002 | B1 |
| 6416574 | Steelhammer | Jul 2002 | B1 |
| 6451104 | Mehta | Sep 2002 | B2 |
| 6457524 | Roddy | Oct 2002 | B1 |
| 6478869 | Reddy et al. | Nov 2002 | B2 |
| 6488763 | Brothers et al. | Dec 2002 | B2 |
| 6488764 | Westerman | Dec 2002 | B2 |
| 6494951 | Reddy et al. | Dec 2002 | B1 |
| 6500252 | Chatterji et al. | Dec 2002 | B1 |
| 6502634 | Evans et al. | Jan 2003 | B1 |
| 6508305 | Brannon et al. | Jan 2003 | B1 |
| 6516884 | Chatterji et al. | Feb 2003 | B1 |
| 6524384 | Griffith et al. | Feb 2003 | B2 |
| 6547871 | Chatterji et al. | Apr 2003 | B2 |
| 6547891 | Linden et al. | Apr 2003 | B2 |
| 6561273 | Brothers et al. | May 2003 | B2 |
| 6562122 | Dao et al. | May 2003 | B2 |
| 6565647 | Day et al. | May 2003 | B1 |
| 6572697 | Gleeson et al. | Jun 2003 | B2 |
| 6610139 | Crook et al. | Aug 2003 | B2 |
| 6626243 | Go Boncan | Sep 2003 | B1 |
| 6641658 | Dubey | Nov 2003 | B1 |
| 6645289 | Sobolev | Nov 2003 | B2 |
| 6645290 | Barbour | Nov 2003 | B1 |
| 6656265 | Garnier et al. | Dec 2003 | B1 |
| 6660080 | Reddy et al. | Dec 2003 | B2 |
| 6664215 | Tomlinson | Dec 2003 | B1 |
| 6666268 | Griffith et al. | Dec 2003 | B2 |
| 6668927 | Chatterji et al. | Dec 2003 | B1 |
| 6668929 | Griffith et al. | Dec 2003 | B2 |
| 6689208 | Brothers | Feb 2004 | B1 |
| 6702044 | Reddy et al. | Mar 2004 | B2 |
| 6706108 | Polston | Mar 2004 | B2 |
| 6708760 | Chatterji et al. | Mar 2004 | B1 |
| 6715568 | Bailey | Apr 2004 | B1 |
| 6716282 | Griffith et al. | Apr 2004 | B2 |
| 6729405 | DiLullo et al. | May 2004 | B2 |
| 6755905 | Oates | Jun 2004 | B2 |
| 6767398 | Trato | Jul 2004 | B2 |
| 6776237 | Dao et al. | Aug 2004 | B2 |
| 6796378 | Reddy et al. | Sep 2004 | B2 |
| 6797054 | Chatterji et al. | Sep 2004 | B2 |
| 6823940 | Reddy et al. | Nov 2004 | B2 |
| 6832652 | Dillenbeck et al. | Dec 2004 | B1 |
| 6835243 | Brothers et al. | Dec 2004 | B2 |
| 6837316 | Reddy et al. | Jan 2005 | B2 |
| 6840318 | Lee | Jan 2005 | B2 |
| 6846357 | Reddy et al. | Jan 2005 | B2 |
| 6848519 | Reddy et al. | Feb 2005 | B2 |
| 6869474 | Perez-Pena et al. | Mar 2005 | B2 |
| 6874578 | Garnier | Apr 2005 | B1 |
| 6883609 | Drochon | Apr 2005 | B2 |
| 6887833 | Brothers et al. | May 2005 | B2 |
| 6889767 | Reddy et al. | May 2005 | B2 |
| 6904971 | Brothers et al. | Jun 2005 | B2 |
| 6908508 | Brothers | Jun 2005 | B2 |
| 6911078 | Barlet-Gouedard et al. | Jun 2005 | B2 |
| 7022755 | Chatterji et al. | Apr 2006 | B1 |
| 7044222 | Tomlinson | May 2006 | B2 |
| 7048053 | Santra et al. | May 2006 | B2 |
| 7077203 | Roddy et al. | Jul 2006 | B1 |
| 7096944 | Vargo et al. | Aug 2006 | B2 |
| 7101829 | Guichard | Sep 2006 | B2 |
| 7174962 | Roddy et al. | Feb 2007 | B1 |
| 7182137 | Fyten et al. | Feb 2007 | B2 |
| 7199086 | Roddy et al. | Apr 2007 | B1 |
| 7204307 | Roddy et al. | Apr 2007 | B2 |
| 7204310 | Roddy et al. | Apr 2007 | B1 |
| 7213646 | Roddy et al. | May 2007 | B2 |
| 7246665 | Almond et al. | Jul 2007 | B2 |
| 7284609 | Roddy et al. | Oct 2007 | B2 |
| 7285164 | Luke et al. | Oct 2007 | B2 |
| 7303015 | Fyten | Dec 2007 | B2 |
| 7335252 | Roddy et al. | Feb 2008 | B2 |
| 7337842 | Roddy et al. | Mar 2008 | B2 |
| 7338923 | Roddy et al. | Mar 2008 | B2 |
| 7341104 | Roddy et al. | Mar 2008 | B2 |
| 7341105 | Bingamon | Mar 2008 | B2 |
| 7350573 | Reddy | Apr 2008 | B2 |
| 7350575 | Lewis et al. | Apr 2008 | B1 |
| 7350576 | Robertson et al. | Apr 2008 | B2 |
| 7353870 | Roddy et al. | Apr 2008 | B2 |
| 7381263 | Roddy et al. | Jun 2008 | B2 |
| 7387675 | Roddy et al. | Jun 2008 | B2 |
| 7395860 | Roddy et al. | Jul 2008 | B2 |
| 7404855 | Chatterji et al. | Jul 2008 | B2 |
| 7409990 | Burts et al. | Aug 2008 | B1 |
| 7431086 | Lewis et al. | Oct 2008 | B2 |
| 7445669 | Roddy et al. | Nov 2008 | B2 |
| 7478675 | Roddy et al. | Jan 2009 | B2 |
| 7530394 | Santra et al. | May 2009 | B2 |
| 7544641 | Robertson et al. | Jun 2009 | B2 |
| 7607482 | Roddy et al. | Oct 2009 | B2 |
| 7607484 | Roddy et al. | Oct 2009 | B2 |
| 7627870 | Michaeli et al. | Dec 2009 | B1 |
| 7631692 | Roddy et al. | Dec 2009 | B2 |
| 7655088 | Bethani | Feb 2010 | B2 |
| 7674332 | Roddy et al. | Mar 2010 | B2 |
| 7741841 | Edwards et al. | Jun 2010 | B2 |
| 7743828 | Roddy et al. | Jun 2010 | B2 |
| 7784542 | Roddy et al. | Aug 2010 | B2 |
| 7789150 | Roddy et al. | Sep 2010 | B2 |
| 7815880 | Constantz et al. | Oct 2010 | B2 |
| 7867954 | Warrender et al. | Jan 2011 | B2 |
| 7922809 | Constantz et al. | Apr 2011 | B1 |
| 7927419 | Roddy | Apr 2011 | B2 |
| 8006446 | Constantz et al. | Aug 2011 | B2 |
| 8029618 | Al-Shafei | Oct 2011 | B2 |
| 8039253 | Asou | Oct 2011 | B2 |
| 8261827 | Roddy | Sep 2012 | B2 |
| 8297357 | Brenneis | Oct 2012 | B2 |
| 8399387 | Roddy et al. | Mar 2013 | B2 |
| 8403045 | Brenneis et al. | Mar 2013 | B2 |
| 8434553 | Brenneis et al. | May 2013 | B2 |
| 8440596 | Brenneis et al. | May 2013 | B2 |
| 8486868 | Brenneis et al. | Jul 2013 | B2 |
| 8486869 | Brenneis et al. | Jul 2013 | B2 |
| 8522873 | Benkely et al. | Sep 2013 | B2 |
| 8544543 | Chatterji et al. | Oct 2013 | B2 |
| 8551923 | Benkley et al. | Oct 2013 | B1 |
| 8554543 | Cherepanov et al. | Oct 2013 | B2 |
| 8555967 | Chatterji et al. | Oct 2013 | B2 |
| 20020033121 | Marko | Mar 2002 | A1 |
| 20020073897 | Trato | Jun 2002 | A1 |
| 20020117090 | Ku | Aug 2002 | A1 |
| 20030116065 | Griffith et al. | Jun 2003 | A1 |
| 20030116887 | Scott | Jun 2003 | A1 |
| 20030167970 | Polston | Sep 2003 | A1 |
| 20040007162 | Morioka et al. | Jan 2004 | A1 |
| 20040040475 | De La Roij et al. | Mar 2004 | A1 |
| 20040079260 | Datta et al. | Apr 2004 | A1 |
| 20040107877 | Getzlaf et al. | Jun 2004 | A1 |
| 20040108113 | Luke et al. | Jun 2004 | A1 |
| 20040112600 | Luke et al. | Jun 2004 | A1 |
| 20040129181 | Lalande et al. | Jul 2004 | A1 |
| 20040182577 | Chatterji et al. | Sep 2004 | A1 |
| 20040187740 | Timmons | Sep 2004 | A1 |
| 20040188091 | Luke et al. | Sep 2004 | A1 |
| 20040191439 | Bour et al. | Sep 2004 | A1 |
| 20040211562 | Brothers et al. | Oct 2004 | A1 |
| 20040211564 | Brothers et al. | Oct 2004 | A1 |
| 20040244650 | Brothers | Dec 2004 | A1 |
| 20040244977 | Luke et al. | Dec 2004 | A1 |
| 20040256102 | Trato | Dec 2004 | A1 |
| 20040262000 | Morgan et al. | Dec 2004 | A1 |
| 20050000734 | Getzlaf et al. | Jan 2005 | A1 |
| 20050034867 | Griffith et al. | Feb 2005 | A1 |
| 20050056191 | Brothers et al. | Mar 2005 | A1 |
| 20050061505 | Caveny et al. | Mar 2005 | A1 |
| 20050072599 | Luke et al. | Apr 2005 | A1 |
| 20050077045 | Chatterj et al. | Apr 2005 | A1 |
| 20050084334 | Shi et al. | Apr 2005 | A1 |
| 20050098317 | Reddy et al. | May 2005 | A1 |
| 20050133221 | Chatterji et al. | Jun 2005 | A1 |
| 20050205255 | Gagliano et al. | Sep 2005 | A1 |
| 20060025312 | Santra et al. | Feb 2006 | A1 |
| 20060054319 | Fyten | Mar 2006 | A1 |
| 20060065399 | Luke et al. | Mar 2006 | A1 |
| 20060081372 | Dealy et al. | Apr 2006 | A1 |
| 20060086499 | Badalamenti et al. | Apr 2006 | A1 |
| 20060166834 | Roddy | Jul 2006 | A1 |
| 20060175060 | Reddy | Aug 2006 | A1 |
| 20060260512 | Nordmeyer | Nov 2006 | A1 |
| 20070056475 | Roddy et al. | Mar 2007 | A1 |
| 20070056479 | Gray | Mar 2007 | A1 |
| 20070089643 | Roddy et al. | Apr 2007 | A1 |
| 20070102157 | Roddy et al. | May 2007 | A1 |
| 20070137528 | LeRoy-Delage et al. | Jun 2007 | A1 |
| 20070186820 | O'Hearn | Aug 2007 | A1 |
| 20070289744 | Bingamon et al. | Dec 2007 | A1 |
| 20080092780 | Bingamon et al. | Apr 2008 | A1 |
| 20080156491 | Roddy et al. | Jul 2008 | A1 |
| 20080229979 | Lewis | Sep 2008 | A1 |
| 20080236814 | Roddy | Oct 2008 | A1 |
| 20080300149 | Reddy et al. | Dec 2008 | A1 |
| 20090044726 | Brouillette et al. | Feb 2009 | A1 |
| 20090088348 | Roddy et al. | Apr 2009 | A1 |
| 20090105099 | Warrender et al. | Apr 2009 | A1 |
| 20090120644 | Roddy et al. | May 2009 | A1 |
| 20090124522 | Roddy et al. | May 2009 | A1 |
| 20090145601 | Bailey | Jun 2009 | A1 |
| 20090200029 | Roddy et al. | Aug 2009 | A1 |
| 20090266543 | Reddy et al. | Oct 2009 | A1 |
| 20090312445 | Roddy et al. | Dec 2009 | A1 |
| 20090320720 | Roddy et al. | Dec 2009 | A1 |
| 20100025039 | Roddy et al. | Feb 2010 | A1 |
| 20100041792 | Roddy et al. | Feb 2010 | A1 |
| 20100044043 | Roddy et al. | Feb 2010 | A1 |
| 20100044057 | Dealy et al. | Feb 2010 | A1 |
| 20100051266 | Roddy et al. | Mar 2010 | A1 |
| 20100051275 | Lewis et al. | Mar 2010 | A1 |
| 20100077922 | Constantz et al. | Apr 2010 | A1 |
| 20100081584 | Perez | Apr 2010 | A1 |
| 20100196104 | Constantz et al. | Aug 2010 | A1 |
| 20100258035 | Constantz et al. | Oct 2010 | A1 |
| 20100258312 | Brenneis et al. | Oct 2010 | A1 |
| 20100273912 | Roddy et al. | Oct 2010 | A1 |
| 20100282466 | Brenneis et al. | Nov 2010 | A1 |
| 20100292365 | Roddy et al. | Nov 2010 | A1 |
| 20100294496 | Woytowich et al. | Nov 2010 | A1 |
| 20100313793 | Constantz et al. | Dec 2010 | A1 |
| 20110000400 | Roddy | Jan 2011 | A1 |
| 20110017452 | Benkley | Jan 2011 | A1 |
| 20110100626 | Brenneis | May 2011 | A1 |
| 20110297378 | Reddy et al. | Dec 2011 | A1 |
| 20120145393 | Roddy | Jun 2012 | A1 |
| 20120152539 | Karcher | Jun 2012 | A1 |
| 20120193097 | Roddy | Aug 2012 | A1 |
| 20120227631 | Roddy | Sep 2012 | A1 |
| 20120234541 | Roddy | Sep 2012 | A1 |
| 20120267107 | Benkley | Oct 2012 | A1 |
| 20120285682 | Santra et al. | Nov 2012 | A1 |
| 20120291674 | Brenneis et al. | Nov 2012 | A1 |
| 20120318506 | Benkley et al. | Dec 2012 | A1 |
| 20120325119 | Brenneis et al. | Dec 2012 | A1 |
| 20120325476 | Brenneis et al. | Dec 2012 | A1 |
| 20120325477 | Brenneis et al. | Dec 2012 | A1 |
| 20120328377 | Brenneis et al. | Dec 2012 | A1 |
| 20130048286 | Morgan et al. | Feb 2013 | A1 |
| 20130061779 | Brenneis et al. | Mar 2013 | A1 |
| 20130112405 | Chatterji et al. | May 2013 | A1 |
| 20130118752 | Hannegan et al. | May 2013 | A1 |
| 20130126159 | Bryan et al. | May 2013 | A1 |
| 20130153214 | Roddy et al. | Jun 2013 | A1 |
| 20130157903 | Benkley et al. | Jun 2013 | A1 |
| 20130213642 | Chatterji et al. | Aug 2013 | A1 |
| 20130213643 | Chatterji et al. | Aug 2013 | A1 |
| 20130233538 | Chatterjie et al. | Sep 2013 | A1 |
| 20130244911 | Benkley et al. | Sep 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 2064682 | Apr 1992 | CA |
| 2336077 | Jan 2000 | CA |
| 2153372 | Jan 2006 | CA |
| 1054620 | Nov 1997 | CN |
| 0814067 | Dec 1997 | EP |
| 1092693 | Apr 2001 | EP |
| 1236701 | Sep 2002 | EP |
| 1319638 | Jun 2003 | EP |
| 1394137 | Jul 2003 | EP |
| 1348831 | Oct 2003 | EP |
| 1900703 | Mar 2008 | EP |
| 2075303 | Jul 2009 | EP |
| 1469954 | Apr 1997 | GB |
| 2455446 | Jun 2009 | GB |
| 52117316 | Oct 1977 | JP |
| 10110487 | Apr 1998 | JP |
| 2026959 | Jan 1995 | RU |
| 2003136028 | May 2005 | RU |
| 1373781 | Feb 1988 | SU |
| WO 8301443 | Sep 1982 | WO |
| 9321122 | Oct 1993 | WO |
| 9721637 | Jun 1997 | WO |
| WO 9854108 | Dec 1998 | WO |
| WO 0063134 | Jan 2000 | WO |
| WO 03031364 | Apr 2003 | WO |
| WO 2004101951 | Nov 2004 | WO |
| WO 2004101952 | Nov 2004 | WO |
| WO 2005047212 | May 2005 | WO |
| WO 2005061846 | Jul 2005 | WO |
| WO 2006032841 | Mar 2006 | WO |
| WO 2007028952 | Mar 2007 | WO |
| 2007041841 | Apr 2007 | WO |
| WO 2007048999 | May 2007 | WO |
| WO 2007128945 | Nov 2007 | WO |
| 2009071962 | Dec 2007 | WO |
| 2006074946 | Jun 2009 | WO |
| WO 2009138747 | Nov 2009 | WO |
| 2012001343 | Jan 2012 | WO |
| Entry |
|---|
| U.S. Appl. No. 13/535,145, filed Jun. 27, 2012, Benkley et al. |
| U.S. Appl. No. 13/560,406, filed Jul. 27, 2012, Brenneis et al. |
| U.S. Appl. No. 13/595,493, filed Aug. 27, 2012, Benkley. |
| U.S. Appl. No. 13/605,875, filed Sep. 6, 2012, Brenneis. |
| U.S. Appl. No. 13/606,098, filed Sep. 7, 2012, Brenneis. |
| U.S. Appl. No. 13/606,120, filed Sep. 7, 2012, Brenneis. |
| U.S. Appl. No. 13/620,013, filed Sep. 14, 2012, Roddy. |
| U.S. Appl. No. 13/620,163, filed Sep. 14, 2012, Roddy. |
| Bartlet-Gouedard, “A Non-Conventional Way of Developing Cement Slurry for Geothermal Wells”, 2001. |
| Poon, “A Study of the Hydration of Natural Zeolite Blended Cement Pastes”, 1999. |
| “Beneficial use of Solid Waste in Maine”, Apr. 14, 2005. |
| Smith, “Cementing” Society of Petroleum Engineers, p. 38, 1990. |
| Smith, “Cementing” Society of Petroleum Engineers, pp. 14, 38, 1987. |
| Chan, Comparative Study of the Initial Surface Absorption and Chloride Diffusion of High Performance Zeolite Silica Fume and PFA concretes, 1999. |
| Rogers, “Designing a Remedial Acid Treatment for Gulf of Mexico Deepwater Turbidite Sands Containing Zeolite Cement”, 1996. |
| Janotka, “Effect of Bentonite and Zeolite on Durability of Cement Suspension Under Sulfate Attack”, 1998. |
| Ding, “Extreme Vertices Design of Concrete With Combined Mineral Admixtures”, 1999. |
| “Kiln Dusts”, Apr. 14, 2005. |
| Sersale, “Portland-Zeolite-Cement for Minimizing Alkali-Aggregate Expansion”, 1987. |
| “Standards for the Management of Cement Kiln Dust Waste”, Apr. 14, 2005. |
| Naiqian, “Study on the Suppression Effect of Natural Zeolite on Expansion of Concrete Due to Alkali-Aggregate Reaction”, 1998. |
| Janotka, “The Properties of Mortar Using Blends With Portland Cement Clinker, Zeolite Tuff and Gypsum”, 1995. |
| Herndon, “Setting Downhole Plugs: A State-of-the-Art, Petroleum Engineer International”, Apr. 1978. |
| Sugama, “Carbonation of Hydrothermally Treated Phosphate-Bonded Calcium Aluminate Cements”, pp. 1-9 (undated but admitted as prior art). |
| Sugama, “Hot Alkali Carbonation of Sodium Metaphosphate Modified Fly Ash/Calcium Aluminate Blend Hydrothermal Cements”, pp. 1661-1672, Sep. 11, 1996. |
| “Use of Cement Kiln Dust for the Stabilization of Soils”, R. L. Parsons, et al., Apr. 14, 2005. |
| Feng, “Zeolite Ceramiste Cellular Concrete”, 2000. |
| Marfil, “Zeolite Crystallization in Portland Cement Concrete Due to Alkali-Aggregate Reaction”, 1993. |
| Atkins, “Zeolite P in Cements”, “Its Potential for Immobilizing Toxic and Radioactive Waste Species”, 1995. |
| HES Brochure “AQF-2 Foaming Agent”, 1999. |
| HES Brochure “Halad-23 Fluid Loss Additive”, 2000. |
| HES Brochure “Halad-344 Fluid Loss Additive”, 1998. |
| HES Brochure “Halad-413 Fluid Loss Additive”, 1999. |
| HES Brochure “Howco Suds Surfactant”, 1999. |
| HES Brochure “HR-12 Cement Retarder”, 1999. |
| HES Brochure “HR-15 Cement Retarder”, 1999. |
| HES Brochure “HR-25 Cement Retarder”, 1999. |
| HES Brochure “HR-4 Cement Retarder”, 1999. |
| HES Brochure “HR-5 Cement Additive”, 1998. |
| HES Brochure “HR-7 Cement Retarder”, 1999. |
| HES Brochure “Pozmix a Cement Additive”, 1999. |
| HES Brochure “Pozmix Cement and Pozmix 140” (undated but admitted as prior art). |
| HES Brochure “SCR-100 Cement Retarder a Valuable Time Saver”, 1994. |
| HES Brochure “SCR-100 Cement Retarder”, 1999. |
| HES Brochure “SCR-500L High Temp Retarder”, 2000. |
| HES Brochure “ThermaLock™ Cement for Corrosive CO2 Environments”, 1999. |
| “3M Scotchlite, Glass Bubbles Floated Product Series Product Information”, 1999. |
| “API Specification for Materials and Testing for Well Cements”, API Spec. 10, 5th ed., pp. 7, 19-21, Jul. 1, 1980. |
| “Appendix A”, API RP 13B-2, 2d ed.; pp. 6-8, Dec. 1, 1991. |
| LaFarge brochure “TerraCem™”, Aug. 2006. |
| LaFarge MSDS “Cement Kiln Dust”, Mar. 3, 2005. |
| LaFarge MSDS “LaFarge Blended Cement (cement)”, Mar. 3, 2005. |
| TXI Material Safety Data Sheet for Pressur-Seal, Oct. 2003. |
| “Manufacture of supplementary cementitious materials from cement kiln dust”, Mishulovich et al., World Cement Research and Development, p. 116-120, Mar. 1996. |
| “Alkali-activated binders by use of industrial by-products”, Buchwald et al., Cement and concrete Research 35, p. 968-973, 2005. |
| Answer 13 of 24 Chemical Abstracts on STN “Manufacture of ceramic particles from floatstone and fly ash”, CN 1182062 (abstract only) (undated but admitted as prior art). |
| Answer 3 of 24 Chemical Abstracts on STN “Effect of cement kiln dust substitution on chemical and physical properties and compressive strength of Portland and slag cements”, Adb El-aleem et al. (abstract only), 2005. |
| Adaska and Taubert, “Beneficial Uses of Cement Kiln Dust”, 2008 IEEE/PCA 50th Cement Industry Technical Conference, Miami, FL, May 19-22, 2008, pp. 1-19. |
| Nelson, “Well Cementing”, 1990. |
| “Fly Ash Resource Center-Pozzolan,” available at http://www.rmajko.com/pozzolan.htm, Apr. 20, 2009. |
| HES Brochure “Enhancer 923™ Cement Agent”, 2010. |
| HES Brochure “Enhancer 923™ Agent—Successes from the Field”, 2010. |
| Office Action from U.S. Appl. No. 11/223,671, Dec. 15, 2005. |
| Office Action from U.S. Appl. No. 11/271,431, Mar. 6, 2006. |
| Office Action from U.S. Appl. No. 11/223,671, Mar. 31, 2006. |
| Office Action from U.S. Appl. No. 11/271,431, May 17, 2006. |
| Office Action from U.S. Appl. No. 11/271,431 (Advisory Action), Jul. 11, 2006. |
| Office Action from U.S. Appl. No. 11/416,563, Jul. 21, 2006. |
| Office Action from U.S. Appl. No. 11/403,032, Jul. 24, 2006. |
| Office Action from U.S. Appl. No. 11/271,431, Aug. 15, 2006. |
| Office Action from U.S. Appl. No. 11/440,627, Aug. 21, 2006. |
| Office Action from U.S. Appl. No. 11/402,741, Oct. 19, 2006. |
| Office Action from U.S. Appl. No. 11/484,951, Oct. 26, 2006. |
| Office Action from U.S. Appl. No. 11/484,951, Dec. 21, 2006. |
| Office Action from U.S. Appl. No. 11/223,703, Jan. 17, 2007. |
| Office Action from U.S. Appl. No. 11/402,741, Feb. 2, 2007. |
| Office Action from U.S. Appl. No. 11/223,485, Feb. 28, 2007. |
| Office Action from U.S. Appl. No. 11/223,669, Feb. 28, 2007. |
| Office Action from U.S. Appl. No. 11/271,690, Mar. 13, 2007. |
| Office Action from U.S. Appl. No. 11/402,741, Mar. 22, 2007. |
| Office Action from U.S. Appl. No. 11/223,703, Apr. 25, 2007. |
| Office Action from U.S. Appl. No. 11/402,741, May 29, 2007. |
| Office Action from U.S. Appl. No. 11/223,669, Jun. 18, 2007. |
| Office Action from U.S. Appl. No. 11/257,261, Aug. 10, 2007. |
| Office Action from U.S. Appl. No. 11/402,741, Sep. 6, 2007. |
| Office Action from U.S. Appl. No. 11/223,669, Oct. 9, 2007. |
| Office Action from U.S. Appl. No. 11/223,750, Oct. 16, 2007. |
| Office Action from U.S. Appl. No. 11/402,741, Oct. 24, 2007. |
| Office Action from U.S. Appl. No. 11/223,669, Jan. 29, 2008. |
| Office Action from U.S. Appl. No. 11/223,669, Apr. 8, 2008. |
| Office Action from U.S. Appl. No. 12/263,800, May 1, 2009. |
| Office Action from U.S. Appl. No. 12/283,398, Jul. 15, 2009. |
| Office Action from U.S. Appl. No. 12/263,800, Jul. 28, 2009. |
| Office Action from U.S. Appl. No. 12/420,630, Aug. 3, 2009. |
| Office Action from U.S. Appl. No. 12/349,676, Nov. 4, 2009. |
| Office Action from U.S. Appl. No. 12/606,381, Mar. 23, 2010. |
| Office Action from U.S. Appl. No. 12/609,993, Apr. 9, 2010. |
| Office Action from U.S. Appl. No. 12/609,993, Jun. 15, 2010. |
| Office Action from U.S. Appl. No. 12/558,097, Jun. 30, 2010. |
| Notice of Allowance from U.S. Appl. No. 12/609,993, Jul. 26, 2010. |
| Office Action from U.S. Appl. No. 12/558,097, Sep. 3, 2010. |
| Office Action from U.S. Appl. No. 12/844,612, Oct. 1, 2010. |
| Office Action from U.S. Appl. No. 12/544,915, Aug. 1, 2011. |
| Office Action from U.S. Appl. No. 12/844,612, Sep. 6, 2011. |
| Office Action from U.S. Appl. No. 12/264,010, Oct. 31, 2011. |
| Office Action from U.S. Appl. No. 12/844,612, Dec. 23, 2011. |
| Final Office Action from U.S. Appl. No. 12/264,010, Apr. 10, 2012. |
| Office Action from U.S. Appl. No. 12/844,612, Apr. 11, 2012. |
| Office Action from U.S. Appl. No. 13/399,913, May 15, 2012. |
| Office Action from U.S. Appl. No. 13/447,560, May 31, 2012. |
| Office Action from U.S. Appl. No. 12/821,412, Jun. 5, 2012. |
| Office Action from U.S. Appl. No. 12/825,004, Jun. 14, 2012. |
| Notice of Allowance from U.S. Appl. No. 13/447,560, Jun. 21, 2012. |
| Office action from U.S. Appl. No. 13/479,476, Jul. 2, 2012. |
| Office action from U.S. Appl. No. 12/975,196, Jul. 3, 2012. |
| Final Office Action from U.S. Appl. No. 12/844,612, Jul. 30, 2012. |
| Notice of Allowance from U.S. Appl. No. 13/399,913, Aug. 23, 2012. |
| Notice of Allowance from U.S. Appl. No. 13/535,258, Sep. 7, 2012. |
| Notice of Allowance from U.S. Appl. No. 12/825,004, Sep. 20, 2012. |
| Foreign Search Report from PCT/GB2005/001415, Sep. 9, 2005. |
| Foreign Search Report from PCT/GB2006/000406, Jul. 5, 2006. |
| Foreign Search Report from PCT/GB2006/003163, Oct. 27, 2006. |
| Foreign Search Report from PCT/GB2006/003160, Nov. 2, 2006. |
| Foreign Search Report from PCT/GB2006/003735, Dec. 1, 2006. |
| Foreign Search Report from PCT/GB2006/003694, Dec. 19, 2006. |
| Foreign Search Report from PCT/GB2006/000401, May 8, 2007. |
| Foreign Search Report from PCT/GB2009/000295, Feb. 3, 2009. |
| Foreign Search Report from PCT/GB2009/000295, Jul. 30, 2009. |
| EPO Application No. 06794648.3 Examination Report, Apr. 17, 2009. |
| EPO Application No. 06779194.7 Examination Report, May 29, 2009. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/000295, Jul. 30, 2009. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/002598, Feb. 11, 2010. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/000295, Aug. 24, 2010. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/001986, Jan. 19, 2011. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/002011, Feb. 4, 2011. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/002018, Mar. 24, 2011. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2011/000933, Sep. 22, 2011. |
| PCT International Search Report and Written Opinion for International Application No. PCT/GB2011/001411, Jan. 27, 2012. |
| English language translation of USSR Patent No. RU 2026959, Jan. 20, 1995. |
| English language translation of Foreign Office Action for Application No. RU2008113765, Jul. 6, 2009. |
| English language translation of Chinese Application No. 200680042014.3, Dec. 1, 2010. |
| Foreign Office Action for Canadian Patent Application No. 2621835, Oct. 2, 2009. |
| Foreign Office Action for Canadian Patent Application No. 2621832, Oct. 5, 2009. |
| Foreign Office Action for Canadian Patent Application No. 2650630, Oct. 14, 2010. |
| Foreign Office Action for Canadian Patent Application No. 2658155, Nov. 16, 2010. |
| Foreign Office Action for Canadian Patent Application No. 2736148, May 29, 2012. |
| Foreign Office Action for CN Patent Application No. 200680042004.X, May 12, 2010. |
| Foreign Office Action for EP Application No. 06 779 199.6, Mar. 1, 2010. |
| Foreign Office Action for EP Application No. 06 779 191.3, Mar. 31, 2010. |
| Foreign Office Action for EP Application No. 06 779 194.7, Jul. 2, 2010. |
| Foreign Office Action for EP Application No. 06 794 646.7, Sep. 24, 2010. |
| Foreign Office Action for EP Application No. 09 713 469.6, Sep. 28, 2010. |
| Foreign Office Action for RU Application No. 2008113766, Jul. 14, 2009. |
| Foreign Office Action for RU Application No. 2008113766, Apr. 8, 2010. |
| Final Office Action from USPTO for U.S. Appl. No. 13/477,777 dated May 29, 2013. |
| Office Action from USPTO for U.S. Appl. No. 13/620,013 dated May 28, 2013. |
| Notice of Allowance from USPTO for U.S. Appl. No. 13/560,406 dated May 29, 2013. |
| Notice of Allowance from USPTO for U.S. Appl. No. 12/895,436 dated May 28, 2013. |
| Notice of Allowance from USPTO for U.S. Appl. No. 13/535,145 dated May 24, 2013. |
| Office Action from USPTO for U.S. Appl. No. 13/851,925 dated Jun. 6, 2013. |
| Office Action from USPTO for U.S. Appl. No. 13/851,391 dated Jul. 3, 2013. |
| Office Action from USPTO for U.S. Appl. No. 13/889,398 dated Jun. 20, 2013. |
| Office Action from USPTO for U.S. Appl. No. 13/872,063 dated Jul. 12, 2013. |
| Office Action from USPTO for U.S. Appl. No. 13/767,710 dated Jul. 19, 2013. |
| Notice of Allowance from USPTO for U.S. Appl. No. 13/851,391 dated Jul. 31, 2013. |
| Notice of Allowance from USPTO for U.S. Appl. No. 13/889,398 dated Aug. 20, 2013. |
| International Preliminary Examination Report and Search Report for PCT/US2013/026162 dated Aug. 26, 2013. |
| Office Action from U.S. Appl. No. 13/477,777 dated Oct. 15, 2012. |
| Notice of Allowance from U.S. Appl. No. 12/844,612 dated Oct. 18, 2012. |
| Final Office Action from U.S. Appl. No. 12/975,196 dated Oct. 23, 2012. |
| Office Action from U.S. Appl. No. 13/555,624 dated Oct. 19, 2012. |
| U.S. Appl. No. 13/662,111, filed Oct. 26, 2012. |
| U.S. Appl. No. 13/669,149, filed Nov. 5, 2012. |
| U.S. Appl. No. 13/872,063 (Chatterji et al.) filed Apr. 23, 2013. |
| U.S. Appl. No. 13/889,398 (Benkley et al.) filed May 8, 2013. |
| U.S. Appl. No. 13/872,063 (Chatterji et al.) filed Apr. 26, 2013. |
| Notice of Allowance, U.S. Appl. No. 13/669,149 (Brenneis et al.) mailed May 13, 2013. |
| U.S. Appl. No. 13/767,710 (Benkley et al.) filed Feb. 14, 2013. |
| U.S. Appl. No. 13/851,391 (Chatterji et al.) filed Mar. 27, 2013. |
| U.S. Appl. No. 13/851,475 (Chatterji et al.) filed Mar. 27, 2013. |
| U.S. Appl. No. 13/851,925 (Chatterji et al.) filed Mar. 27, 2013. |
| U.S. Appl. No. 13/725,833 (Chatterji et al.) filed Dec. 21, 2012. |
| Office Action for U.S. Appl. No. 13/725,833 (Chatterji et al.) dated Apr. 10, 2013. |
| International Search Report for PCT/GB2011/001749 dated Apr. 5, 2012. |
| International Search Report and Written Opinion for PCT/GB2010/000712 dated Jul. 26, 2010. |
| Office Action for U.S. Appl. No. 13/620,013 dated Feb. 26, 2013. |
| International Search Report and Written Opinion for PCT/GB2011/000932 dated Sep. 22, 2011. |
| USPTO Office Action for U.S. Appl. No. 13/560,406 dated Oct. 17, 2012. |
| Office Action from USPTO for U.S. Appl. No. 13/431,701 dated Nov. 9, 2012. |
| Office Action from USPTO for U.S. Appl. No. 13/620,163 dated Nov. 9, 2012. |
| International Search Report and Written Opinion for PCT/US2012/046117 dated Oct. 26, 2012. |
| Office Action from USPTO for U.S. Appl. No. 13/669,149 dated Dec. 19, 2012. |
| Office Action from USPTO for U.S. Appl. No. 13/606,098 dated Dec. 13, 2012. |
| HES Brochure “VersaCem™ Cement” dated Jan. 2007. |
| Notice of Allowance for U.S. Appl. No. 13/662,111 dated Oct. 21, 2013. |
| Office Action for U.S. Appl. No. 13/620,013 dated Oct. 2, 2013. |
| Office Action for U.S. Appl. No. 13/851,925 dated Sep. 20, 2013. |
| Office Action for U.S. Appl. No. 13/180,238 dated Sep. 25, 2013. |
| Office Action for U.S. Appl. No. 13/767,710 dated Sep. 20, 2013. |
| Office Action for U.S. Appl. No. 13/477,777 dated Sep. 20, 2013. |
| International Search Report and Written Opinion for PCT/US2013/056719 dated Oct. 25, 2013. |
| Number | Date | Country | |
|---|---|---|---|
| 20140076204 A1 | Mar 2014 | US |
